|
19 November 2004
Glasgow company Diagnostic Potentials Ltd will receive an award tonight (Friday, November 19th) from Scotlands leading economic development organisation for its pioneering work to improve the diagnosis of people suffering from Alzheimer's disease.
The company, a spin-out from Glasgow Universitys Department of Psychology, has developed medical technology which helps with the early diagnosis of the disease. It is being honoured by the Scottish Council for Development and Industry at its Gala Awards ceremony in Glasgow with the Pfizer Award for Innovation in Life Sciences.
The prize will be presented by the Secretary of State for Scotland Alistair Darling.
SCDI Chief Executive Alan Wilson said:
Scotlands economic prosperity depends on getting many more ideas and inventions out of our leading university labs and into production. Diagnostic Potentials Ltd, a spin-out company from Glasgow University, is a trailblazer in this respect and has enhanced Scotlands reputation in life sciences.
SCDIs award recognises the firms development of a device to help with the early diagnosis of Alzheimers disease which affects 18 million people worldwide and this year claimed our own Rikki Fulton. It has the potential to be a big breakthrough as early intervention improves care and maximises the effectiveness of drug therapies.
The award will be accepted by Diagnostic Potentials Ltd Chief Executive Dr Kerry Kilborn. He said:
We are pleased that SCDI and Pfizer have recognised the company's work on the early detection of Alzheimer's disease, which will reach the clinical market in a few months time. More importantly, we welcome the contribution this recognition makes toward raising awareness of the need to pursue research and development on all fronts to combat this devastating disease.
Back to Latest News
|
